๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Infliximab: Use in inflammatory bowel disease

โœ Scribed by Win J. Travassos; Adam S. Cheifetz


Book ID
107556396
Publisher
Springer
Year
2005
Tongue
English
Weight
342 KB
Volume
8
Category
Article
ISSN
1092-8472

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Are accelerated infliximab infusions saf
โœ Shivaram Bhat; Divyesh Sharma; Pauline Doherty; Tony C.K. Tham; Grant R. Caddy ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 99 KB

Background: Infliximab is a monoclonal antibody used in the treatment of inflammatory bowel disease (IBD). The manufacturerrecommended administration is over 2 hours followed by 2 hours of patient observation. The data relating to adverse outcomes in patients receiving accelerated infusions for IBD

Inflammatory Bowel Disease
โœ Aravind Suppiah; Jonathon Cowley; Chris Macklin ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› Springer ๐ŸŒ English โš– 144 KB